重磅!钱江就任百时美施贵宝中国总经理

谈思生物
10 Jul

2025.07.10本文字数:1987,阅读时长大约5分钟导读:BMS中国换帅,资深“老将”钱江升任总经理,曾主导多款重磅新药上市,未来或将加速创新药在华商业化进程。大约一年半前,钱江带领数十位团队成员加入百时美施贵宝(BMS),继续推动全球首创药物玛伐凯泰的上市与商业化进程。凭借出色的业绩表现,他在不到一年的时间内便被任命为BMS中国大陆及香港地区的商业化负责人。如今,他迎来了职业生涯中的又一...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10